Tandem Diabetes Care (TNDM) Other Non-Current Liabilities (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Other Non-Current Liabilities came in at $50.4 million in Q1 2026, up 36.01% YoY from $37.1 million in Q1 2025, and up 1.35% on a QoQ basis from $49.7 million in Q4 2025.
Tandem Diabetes Care (TNDM) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Other Non-Current Liabilities data on file, last reported at $50.4 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 36.01% year-over-year to $50.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.4 million (up 36.01% YoY) and the FY2025 annual result came in at $49.7 million, up 53.67% from the prior year.
- Other Non-Current Liabilities climbed to $50.4 million in Q1 2026, from $49.7 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $52.4 million in Q3 2025 to a low of $17.2 million in Q2 2022.
- A 5-year average of $32.8 million and a median of $32.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 19752.59% in 2022, down 38.28% in 2022.
- Tracing TNDM's Other Non-Current Liabilities over 5 years: stood at $23.9 million in 2022, then jumped by 33.08% to $31.8 million in 2023, then gained by 1.69% to $32.4 million in 2024, then soared by 53.67% to $49.7 million in 2025, then climbed by 1.35% to $50.4 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $50.4 million (Q1 2026), $49.7 million (Q4 2025), and $52.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.05 Mn |
| Mar 31, 2026 | 50.41 Mn |
| Dec 31, 2025 | 49.74 Mn |
| Sep 30, 2025 | 52.38 Mn |
| Jun 30, 2025 | 52.07 Mn |
| Mar 31, 2025 | 37.07 Mn |
| Dec 31, 2024 | 32.37 Mn |
| Sep 30, 2024 | 32.24 Mn |
| Jun 30, 2024 | 32.50 Mn |
| Mar 31, 2024 | 32.48 Mn |
| Dec 31, 2023 | 31.83 Mn |
| Sep 30, 2023 | 24.12 Mn |
| Jun 30, 2023 | 24.95 Mn |
| Mar 31, 2023 | 23.80 Mn |
| Dec 31, 2022 | 23.92 Mn |
| Sep 30, 2022 | 23.03 Mn |
| Jun 30, 2022 | 17.24 Mn |
| Mar 31, 2022 | 17.45 Mn |
| Dec 31, 2021 | 17.84 Mn |
| Sep 30, 2021 | 116,000.00 |